FDA Approves THC product from Insys | O’Shaughnessy’s


The US Food and Drug Administration (FDA) has approved dronabinol oral solution (Syndros, Insys Therapeutics, Inc) for the treatment of anorexia associated with weight loss in patients with AIDS and for nausea and vomiting associated with cancer chemotherapy in patients who fail to respond adequately to conventional antiemetic treatments, according to a company news release.

Read more at  FDA Approves THC product from Insys | O’Shaughnessy’s


Leave a comment

Your email address will not be published. Required fields are marked *